Thirty years ago, I discovered a new enzyme, glycoamidase A that cleaves carbohydrate moiety from glycopeptides without aŠecting peptide structures. This brought me to determination that I should commit comprehensive analysis of N-linked oligosaccharide structures in glycoproteins by using this enzyme. Now, the HPLC mapping method developed by myself is a powerful tool to identify the structures of N-glycans. Here I described my 30 years in the dream of the structural analyses of the Nlinked oligosaccharides from the discovery of glycoamidase A to the development of the GALAXY database.
A. Introduction
In 1977, when I was working as an associate Professor in the Medical School of Nagoya City University, I discovered a new enzyme that cleaves the intact Nlinked carbohydrate moiety from a glycoprotein without aŠecting the carbohydrate or peptide structures, and I named this enzyme as glycoamidase A (1-3).
I discovered one such enzyme, which was a previously undetected byproduct of a crude almond-derived bglucosidase preparation supplied by the Sigma-Aldrich Corporation. The International Enzyme Committee named the enzyme after its discoverer (Noriko Takahashi) and gave it an independent new number, EC. 3.5.1.52. Since then, I have been conducting comprehensive analyses of the N-linked oligosaccharide structures in glycoproteins by using this enzyme. Fortunately, it was shortly after her professor had suddenly moved out of the school and she had the opportunity to carry on this project.
At that time, the author had been working on determination of the primary amino acid sequence of Stem Bromelain (4), a pineapple proteolytic enzyme, which had been known as a glycoprotein (this work was one of the works assigned by the former professor). The presence of the sugar moieties was really an obstruction in the Bromelain project. She therefore dreamed that she could have an enzyme that would cleave these carbohydrate chains from the protein without aŠecting the peptide structures.
The dream came true. All of the sudden, this enzyme appeared in front of her eyes. She was convinced that this was a gift from the Goddess of Science to a humble female scientist struggling and being frustrated in a male-dominant Japanese academic world. This new enzyme had been hiding in the crude b-glucosidase supplied by Sigma product.
At that time, although the amino acid sequences of glycoproteins could be determined by using ordinary methods, there was no suitable technique for performing detailed structural analysis of the oligosaccharides attached to the same protein. Therefore, I started analyzing the unknown carbohydrate structures that were cleaved from various glycoproteins by this new enzyme. To this end, I have performed structural studies of the oligosaccharide moieties of stem bromelain (4) (1979), ovalbumin (5) (1981), humanˆbrinogen (6) (1981), proteoglycan-core molecules (7) (1982), glycoproteins in the human placenta and umbilical cord (8) (1982), Taka-amylase A apoprotein (9) (1982), and the Fc region of a human IgD (10) (1983), etc.
In 1988 (11 years after from the discovery of the Glycoamidase A), she, on the basis of the accumulated oligosaccharide structural data, I published theˆndings of a new analytical technique, namely,``two dimensional (2D)-mapping method,'' along with the structures of 113 neutral examples (11) ; this method could be used to separate and determine the similarities in the structures of N-linked oligosaccharide moieties of glycoproteins. In 1988, using this new method, my group analyzed samples of urinary and recombinant human erythropoietin (12) and determined the structures of more than 8 types of urinary N-linked oligosaccharides and 13 types of recombinant N-linked oligosaccharides in the human erythropoietin samples. To date, I have been continuing my research project on this topic. In 1995, I published another paper outlining a 3D-mapping method (13) along with descriptions of 220 neutral structures and 42 diŠerent sialyl oligosaccharides, of which 26 were monosialylated, 7 were disialylated, 7 were trisialylated, and 2 were tetrasialylated.
In the 30 years since the discovery of glycoamidase A in 1977, my group has determined and mapped the 2D/3D data of more than 600 pyridylaminated (PA) Nglycan structures (14) , including both sialic-acid-containing oligosaccharides and sulfuric-acid-containing oligosaccharides (15) . Furthermore, we have developed a web application,``GALAXY'' (Glycoanalysis by the 3 axes of MS and chromatography, http://www.glycoanalysis. info/) (16), on the basis of these accumulated data.
B. Analysis methods B-1. Glycoamidase A
The reaction mechanism of glycoamidase A is shown in Fig. 1 . So far, this enzyme has been found to be capable of cleaving all N-linked oligosaccharides in glycopeptides at the linkage indicated by the black arrow, irrespective of whether the oligosaccharides are neutral, sialylated, sulfated, or phosphorylated.
As of today, GALAXY (16), which will be described later, contains the information for more than 600 oligosaccharides, all of which has been obtained using digestion with the abovementioned glycoamidase. 
B-2. Two-dimensional mapping
In 1988, we proposed the 2D-mapping technique (11) for the structural analyses of PA-neutral oligosaccharides. This method uses 2 diŠerent high-performance liquid chromatography (HPLC) columns. Before analysis, the reducing oligosaccharide mixture is derived from the glycopeptide portion by glycoamidase digestion. Then, it is derivatized with 2-aminopyridine to induce ‰uorescence. We found that Dr. Hase's improved method for PAderivatization is suitable for both sialylated and neutral oligosaccharides. Because of the ‰uorescent nature of the sample, the method has picomole-level sensitivity in the detection of PA-oligosaccharides.
Before sample (PA-derivatized oligosaccharide) application on the HPLC columns, we calibrated both the columns with isomalto-oligosaccharide mixtures. Theˆrst separation of the sample oligosaccharide was performed on a calibrated octadecylsilyl (ODS)-silica column (for example, the GU 14.7 peak on Fig. 2, left, up) . The second separation of the sample oligosaccharide was performed on an amide-silica column (the GU 6.7 peak on Fig. 2 , left, down). Finally, we plotted the calibrated elution-time factors on a 2-D map (Fig. 2, right) and compared them to the elution times of previously analyzed structures.
This method can not only separate oligosaccharides but also identify the structure of the target oligosaccharide. 
B-3. Three-dimensional mapping
In 1995, in order to facilitate the analysis of oligosaccharides with acidic groups, i.e., sialylated (13), sulfated (15) , or phosphorylated groups, the 2D map was upgraded to a 3D map (Fig. 3) . Currently, over 600 Nlinked oligosaccharides are distributed on the 3-D map.
The present 3-D mapping method involves the following steps:ˆrst, a mixture of neutral and sialyl PAoligosaccharides is separated according to the sialic acid content by using HPLC on a diethylaminoethyl (DEAE) column. In the second and third steps, neutral, mono-, di-, tri-and tetrasialyl oligosaccharides are separated on ODSsilica and amide-silica columns. The data points for each acidic group are plotted on separate 2-D maps, with ODSelution units on the X-axis and amide units on the Y-axis. Finally, in the fourth step, the individual 2-D maps are combined into a 3-D map, with acidity as the Z-axis.
These 3D maps can clearly diŠerentiate between the closely related sialic a2,3-and a2,6-containing oligosaccharides. 
B-4. The unit-contribution (UC) concept
In 1990, 1991, and 1993, we published theˆndings of a new concept,``parameterization by unit contribution'' (17) (18) (19) . Here,``unit'' refers to individual monosaccharide components at speciˆc positions in an N-linked oligosaccharide. For example, in Fig. 4 , on the ODS column, the elution time (GU) of the entire high-mannose oligosaccharide (containing 9 mannose residues) is 5.2. This value can be expressed as a total of the unit contributions of the participating units. In the case of an amide column, thisˆnding is more or less expected, considering that the elution time on an amide column is proportional to the molecular size, at least for the neutral oligosaccharides. Surprisingly, we found that the elution times on the ODS column can also be expressed as a total of the unit contributions. For example, in the case of the high-mannose oligosaccharide (containing 9 mannose residues) shown in Fig. 4 , the ODS-elution time (GU) of the entire molecule was 5.2. This value is equal to the total of the unit contributions of all mannose residues in the molecule.
The calculated UC values are useful in suggesting the glycan structure on the basis of the resulting GUs. For example, Man8GlcNAc2, which is obtained by a-mannosidase digestion of Man9GlcNAc2, can produce 3 possible structures depending on which of the terminal mannose residues on the left side has undergone cleavage. The actual resulting structure can be identiˆed on the basis of the observed glucose units on the ODS column. If the experimental ODS GU value for a-mannosidase digestion is 6.4, one can conclude that the uppermost terminal mannose (unit contribution, -1.07) was cleaved. Since the other 2 possibilities would have resulted in ODS GUs of 4.8 and 5.7, they can be excluded from consideration.
C. Examples of oligosaccharide structures
This section describes some interesting N-glycan structural analyses that were performed using the 2D-and 3D-mapping methods.
C-1. Human IgG N-glycans
The N-glycans from human IgG exhibit complex microheterogeneity with 16 neutral components, as shown in Fig. 5 . In particular, components F and G have the same molecular weight and very similar structures. Therefore, reliable separation of the peaks corresponding to these complicated N-glycans requires elution proˆles with a very high resolution. This requirement was achieved by precise control of the buŠer conditions during the HPLC procedure. Fig. 6 demonstrates the age-related changes in the IgG-oligosaccharide proˆles of 2 healthy males aged 81 years and 29 years. The diŠerence is well pronounced even in the limited data shown at this instance (only neutral HPLC proˆles). In the aged subject, peak E (agalactosyl, G0) is predominant. In contrast, a predominant peak H (digalactosyl, G2) and lower levels of G0 and G1 are characteristic in the younger subject. Note the clear separation of the F and G components on the ODS HPLC column, in spite of their very similar structures. Similarly, there were distinct diŠerences between the IgG-oligosaccharide proˆles of males and females, as shown in the analysis of samples from a healthy 27-yearold male and a healthy 24-year-old female (not shown here). The diŠerence was characterized by the presence of a predominant peak H (digalactosyl) in the female in contrast to the relatively lower peak H in the male.
Another study (20) was theˆrst to show the diŠer-ences between normal and pathological human IgG oligosaccharides by using HPLC.
C-2. Chlamydia trachomatis oligosaccharides
It is generally believed that N-linked oligosaccharides are rarely present in bacteria. However, Kuo et al found that these oligosaccharides are involved in C. trachomatis infection of Hela cells (21) . The N-linked oligosaccharides in the membrane protein of C. trachomatis were exclusively composed of high-mannose type oligosaccharides ranging from M-5 to M-9 (Fig. 7) . Interestingly, the shortest elution time on an ODS column was not for M-9, but for M-8, which was followed by M-9, M-7, M-6, andˆnally, M-5.
C-3. Oligosaccharide structures in squid rhodopsin
Rhodopsin exists in the photoreceptor cells, and the rhodopsin N-terminal segment is N-glycosylated. We have reported the structures in Eur. J. Biochem. in 2003 (22) . The major N-glycan structure of squid rhodopsin is shown below. 
We found the characteristic sequence (Galb(1,4) Fuca(1,6), which was previously found in octopuses. Furthermore, our study was theˆrst to demonstrate the occurrence of an insect-speciˆc N-glycan sequence in mollusks; the innermost N-acetylglucosamine residue of this N-glycan sequence was difucosylated.
C-4. High-mannose oligosaccharides (M7) in Golgi particles and cell membrane In the amide HPLC data, the proportion of highmannose-type oligosaccharides (M7) in the Golgi particles and the cell membrane of insect cells appears to be approximately equal (Fig. 8) . However, on the ODS column, the M7 peak splits into 2 peaks, namely, M7.1 and M7.2, and there are signiˆcant diŠerences between their ratios in the membrane and the Golgi particles. Theseˆndings demonstrate the importance of successive application of 2 types of HPLC columns (2-D mapping method) for diŠerentiat-ing structures.
This work was a collaboration with Dr. Kosei Takeuchi of Nagoya University at that time and Mr. Soji Murayama of Katakura Industries Co., Ltd.
D. The GALAXY data base
The data for all N-glycan structures analyzed so far has been compiled in the GALAXY data base and made available online (16) . Fig. 9 shows the homepage of the online system. The position of each point corresponds to a single N-linked oligosaccharide with a speciˆc structure.
E. Summary
Most N-linked oligosaccharides can be completely released from their original glycopeptides by glycoamidase A digestion, regardless of their origin, size, acidity, structure etc. The 2D/3D mapping method for identifying Nlinked oligosaccharide structures is an extremely reproducible and reliable method with femtomole-level sensitivity. This procedure can be used to easily identify the structures of newly isolated oligosaccharides. Currently, the GALAXY database contains the data for over 600 N-linked oligosaccharides.
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